Ramírez Medina, Carlos Raúl
Ali, Ibrahim
Baricevic-Jones, Ivona
Saleem, Moin A.
Whetton, Anthony D.
Kalra, Philip A.
Geifman, Nophar
Funding for this research was provided by:
Medical Research Council (MR/R013942/1)
Manchester Biomedical Research Centre (NIHR203308)
Article History
Received: 16 February 2024
Accepted: 25 April 2024
First Online: 18 May 2024
Declarations
:
: Plasma samples were collected and processed as part of the Salford Kidney Study (SKS). SWATH-MS protein quantification was carried out at Stoller Biomarker Discovery Centre, The University of Manchester, UK. Data was analysed by The University of Manchester and The University of Surrey.
: The results presented in this paper have not been published previously in whole or part. All consents obtained prior to publication.
: Prof. Kalra received speaker and/or advisory board fees from Astra Zeneca, Napp, Bayer, GSK, Boehringer Ingelheim, Vifor, Pharmacosmos, Novonordisk. Prof. Saleem performs consultancy work for: Travere; Confo therapeutics; Purespring Therapeutics. All other authors report no conflict of interest regarding this manuscript.